Invitae Corporation(NVTA)

Sector:

Healthcare

Description:

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Current Price

$1.07

RSI

36.68

Market Capitalization:

1.8B

Beta:

1.804

Volume:

8,170,296

Analyst Target Price:

$ 21.68

Economiic Fair Price:


November 08, 2022
November 08, 2022
Q3
N/A
N/A
N/A
N/A
N/A
217M
1.8B
-1.797
-82.30 %
2.183
-0.153

19.79 %
-588.03 %
-29.48 %
16.73 %
-48.13 %
22.34 %

$ 460.4M
64.68 %
$ 279.6M
28.95 %
$ 216.8M
46.80 %
$ 147.7M
116.50 %
$ 68.2M
172.36 %
$ 25M

$ -614.5M
-91.23 %
$ -321.4M
-94.65 %
$ -165.1M
-68.14 %
$ -98.2M
6.18 %
$ -104.7M
-19.01 %
$ -87.9M

$ -415.9M
41.78 %
$ -714.3M
-174.28 %
$ -260.4M
-97.05 %
$ -132.2M
-5.52 %
$ -125.2M
-24.92 %
$ -100.3M

News

Press Releases

Notable Dates